Literature DB >> 1510195

Megakaryocytes and megakaryocyte progenitors in human cord blood.

T A Olson1, R F Levine, E M Mazur, D G Wright, A J Salvado.   

Abstract

Thrombocytopenia contributes significantly to morbidity in the sick term or preterm infant. However, few data exist on newborn's megakaryocytes and megakaryocyte progenitor cells (CFU-MK). We therefore studied CFU-MK in term and preterm infant cord blood and compared the results with data on CFU-MK from adult bone marrow and adult peripheral blood in a plasma clot culture with postirradiated aplastic canine serum (PIACS) as a source of megakaryocyte colony-stimulating activity. The number of CFU-MK and the number of cells per CFU-MK were counted with an immunofluorescent method at day 12. The effect of T-lymphocyte depletion on cord blood cultures for CFU-MK was studied with PIACS and a partially purified product of PIACS. We also studied individual megakaryocytes from newborns. The number and sizes of circulating megakaryocytes, isolated from adult peripheral blood and term venous cord blood by elutriation, were compared. Term and preterm cord blood contained more CFU-MK than adult peripheral blood. The numbers of CFU-MK in preterm cord blood were comparable to those in adult bone marrow. When the number of cells per colony were compared, cord blood contained significantly more cells than adult marrow CFU-MK. The depletion of T lymphocytes did not significantly change the growth of CFU-MK compared to nondepleted cultures. A substantial number of circulating megakaryocytes were obtained from venous cord blood, though they were significantly smaller than adult peripheral blood megakaryocytes. Since cord blood is easily obtained and contains large numbers of megakaryocytes and CFU-MK, it may provide a convenient model for studying the regulation of fetal megakaryocytopoiesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510195     DOI: 10.1097/00043426-199208000-00011

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  6 in total

Review 1.  Neonatal thrombocytopenia and megakaryocytopoiesis.

Authors:  Francisca Ferrer-Marin; Zhi-Jian Liu; Ravi Gutti; Martha Sola-Visner
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

2.  Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes.

Authors:  Karen M Pastos; William B Slayton; Lisa M Rimsza; Linda Young; Martha C Sola-Visner
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

Review 3.  Changes in megakaryopoiesis over ontogeny and their implications in health and disease.

Authors:  Patricia Davenport; Zhi-Jian Liu; Martha Sola-Visner
Journal:  Platelets       Date:  2020-03-21       Impact factor: 3.862

Review 4.  New insights into the mechanisms of nonimmune thrombocytopenia in neonates.

Authors:  Martha Sola-Visner; Hannes Sallmon; Rachel Brown
Journal:  Semin Perinatol       Date:  2009-02       Impact factor: 3.300

5.  Fetal vs adult megakaryopoiesis.

Authors:  Patricia Davenport; Zhi-Jian Liu; Martha Sola-Visner
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

6.  Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS).

Authors:  Maria Chiara Pelleri; Allison Piovesan; Maria Caracausi; Anna Concetta Berardi; Lorenza Vitale; Pierluigi Strippoli
Journal:  BMC Med Genomics       Date:  2014-12-05       Impact factor: 3.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.